<DOC>
	<DOCNO>NCT02467348</DOCNO>
	<brief_summary>All consecutive patient admit ILBS MAY 2015 DECEMBER 2016.ACLF ( Acute chronic Liver Failure ) . ACLF randomize Group 1 : MVP ( Modest Volume Paracentesis ) OF Less 5 liter IV albumin dose 8 gms/L ascitic fluid Group 2 : MVP ( Modest Volume Paracentesis ) Less 5 liter without albumin</brief_summary>
	<brief_title>Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure .</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>1 . All patient acute hepatic insult manifest jaundice ( Sr. Bil . ≥ 5 mg/dL ) coagulopathy ( INR≥1.5 ) , complicate within 4 week ascites and/or encephalopathy patient previously diagnose undiagnosed chronic liver disease ( ACLF ) admit hospital . 2 . All Cirrhotics decompensated ascites admit hospital . 3 . Grade II/III ascites 4 . Need paracentesis . 1 . Age &lt; 12 &gt; 75 year 2 . Hepatocellular carcinoma 3 . Non cirrhotic ascites malignancy tubercular peritonitis 4 . Serum Cr &gt; 1.5mg % 5 . Refractory septic shock 6 . Grade III/IV hepatic encephalopathy 7 . Abdominal wall cellulitis 8 . Active variceal bleed 9 . Respiratory , cardiac renal failure 10 . Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>